CAR Technology: A New Approach to Treating Autoimmune Diseases
Researchers are exploring the use of chimeric antigen receptor (CAR) technology to target and eliminate specific cells involved in autoimmune diseases, including Type 1 diabetes.
Key takeaways
- CAR technology involves engineering immune cells to target specific cells or restore balance to the immune system.
- This approach has shown promise in treating autoimmune disorders, infectious diseases, and fibrotic lesions.
- Researchers are working to address concerns about CAR cell persistence, safety, and manufacturing accessibility.
What is CAR Technology?
CAR technology is a type of immunotherapy that involves engineering immune cells to target specific cells or restore balance to the immune system. This approach has been used successfully in cancer treatment, but researchers are now exploring its potential in treating non-cancerous diseases.
How Does CAR Technology Work?
In autoimmune diseases like Type 1 diabetes, the immune system mistakenly attacks healthy cells. CAR technology involves engineering T cells to recognize and eliminate these pathogenic cells. This approach can also be used to restore balance to the immune system by using engineered regulatory T cells (Tregs) to control augmented immune effector responses.
Potential Applications of CAR Technology
Researchers are exploring the use of CAR technology to treat a range of autoimmune diseases, including Type 1 diabetes. This approach has also shown promise in treating infectious diseases and fibrotic lesions. Additionally, CAR technology may have therapeutic potential for inflammatory bowel disease.
Evidence label
Source: Frontiers in immunology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.